Conversational AI Trial Search
AI-native approach to identifying and navigating patients to clinical trials using plain language queries
Software · Cloud SaaSCompany source
Company profile
About Trial Library
Trial Library is building the infrastructure that connects patients to clinical trials as a standard part of care delivery. The company operates an AI-native platform that integrates clinical trials into routine healthcare by activating providers, identifying eligible patients, and supporting them through the complete trial lifecycle. Founded by physician-scientist Dr. Hala Borno, Trial Library addresses a critical gap in healthcare: while 85% of cancer patients receive care in community settings, access to clinical trials has historically been concentrated in academic medical centers. The platform serves three key stakeholders: health systems and providers who can refer patients in under a minute without new systems or logins; biopharma sponsors who gain access to pre-qualified patients and faster enrollment; and payers and employers who can integrate clinical trial access into member benefits. Trial Library's technology includes Conversational AI Trial Search for natural language querying of protocols, Internal Referral Optimization that analyzes existing patient populations to match them to open trials, and an Intelligent Navigation OS that uses AI to proactively address barriers like transportation, food, language, and scheduling throughout the trial journey. The company operates one of the country's most dynamic research networks, spanning over 840 clinics and 3,000+ providers nationwide, partnering with leading health systems, pharma sponsors, and health plans to create a coordinated research ecosystem built around the patient.
Company description Trial Library official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Trial Library?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- cancer
- oncology
Who it serves
- Academic Centers
- Community Oncology Clinics
- Employers
- Health Systems
- Payers
- Pharma Sponsors
- Specialty Practices
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
Raised $10 million Series A funding in December 2025 co-led by SemperVirens Venture Capital and NEXT Ventures; launched Conversational AI Trial Search; expanded to 840+ clinics and 3,000+ providers; hired Chief Product Officer Karim Damji in September 2025
Partnerships
Recorded partners
- health plans
- leading global biopharmaceutical manufacturers
- Sanofi Ventures
- self-insured plans
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Health Provider Activation
Equip providers with intelligent pre-screening, seamless referrals, and workflows for clinical trial access
Platform · Cloud SaaSCompany source
Intelligent Navigation OS
AI-powered patient navigation supporting trial completion by addressing barriers proactively
Platform · Cloud SaaSCompany source
Internal Referral Optimization
Site augmentation that analyzes existing patient populations to match patients to open trials
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized germline genetic registry.Contemporary clinical trials communications · Oct 1, 2026
Machine learning modelling for predicting the utilization of invasive and non-invasive ventilation throughout the ICU duration.Healthcare technology letters · Aug 1, 2024
Qualitative Study on Internet Use and Care Impact for Black Men With Prostate Cancer.Health education & behavior : the official publication of the Society for Public Health Education · Jun 1, 2024
Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer.The Journal of urology · Mar 1, 2024
The costs and inequities of precision medicine for patients with prostate cancer: A call to action.Urologic oncology · Sep 1, 2023
The Effect of Racial Concordance on Patient Trust in Online Videos About Prostate Cancer: A Randomized Clinical Trial.JAMA network open · Jul 3, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Faster enrollment
for biopharma sponsors through pre-qualified patient pipeline
Patient referral in under a minute
for providers without new systems
Increased pre-screening volume
through site augmentation and population analysis
Community Oncology Network
Expanding clinical trial access to community oncology settings where 85% of cancer patients receive care
3000+ providers and 840+ clinics onboarded across nationwide research network
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Trial Library
Recent articles published on Trial Library's official website.
May 20, 20264min readTrial Library today announced the launch of Conversational AI Trial Search, a new AI-native approach to identifying and navigating patients to clinical trials.by:Trial Library
Read on Trial LibrarySeptember 19, 2025With over two decades of experience driving growth and innovation in digital health and health tech, Karim brings a unique blend of strategic leadership, product insight, and startup success to our mission.by:Trial Library
Read on Trial LibrarySeptember 16, 2025This Prostate Cancer Awareness Month, we're sharing John's story – a powerful reminder that the right support can make all the difference in a patient's clinical trial journey.by:Trial Library
Read on Trial LibrarySeptember 16, 2025We’re thrilled to welcome James Jack to the Trial Library team as our new Head of BioPharma Partnerships.by:Trial Library
Read on Trial Library07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.